Low-dose aspirin can indirectly prevent the upregulation of COX-2-dependent signaling pathways that promote cancer development by affecting platelet function (Patrignani and Patrono, 2016; Patrignani and Patrono, 2018). This evidence concerns the gene PTGS2 and cancer.